Gene: SMUG1 ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.100 Biomarker disease BEFREE Intense Choline Activity in Renal Cell Carcinoma Without Obvious 18F-FDG Uptake. 30371589 2019
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.100 Biomarker disease BEFREE Imaging of renal cell carcinoma in patients with acquired cystic disease of the kidney: comparison <sup>11</sup>C-choline and FDG PET/CT with dynamic contrast-enhanced CT. 30377936 2019
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.100 Biomarker disease BEFREE Texture analysis of 18F-FDG PET/CT could effectively differentiate between RCCs and renal lymphomas. 31140234 2019
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.100 Biomarker disease BEFREE We present a case of HLRCC syndrome-associated RCC showing high FDG uptake in both the primary RCC and retroperitoneal lymph node metastases. 30762823 2019
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.100 Biomarker disease BEFREE In this paper, we assess FDG PET/CT as a survival prognostic marker in patients with advanced RCC. 30488140 2019
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.100 Biomarker disease BEFREE Castleman's Disease of the Kidney Mimicking Renal Cell Carcinoma on FDG PET/CT. 29432340 2018
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.100 Biomarker disease BEFREE FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma. 29464355 2018
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.100 Biomarker disease BEFREE This case highlights the role of FDG PET/CT in staging and restaging this type of rare renal cell carcinoma. 29485439 2018
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.100 Biomarker disease BEFREE Several databases were searched for relevant articles on F-FDG PET or PET/CT for the restaging of RCC. 27824726 2017
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.100 Biomarker disease BEFREE Fifty-six patients with metastatic RCC who underwent F-FDG PET/CT for staging and recurrence evaluation were retrospectively enrolled. 28288043 2017
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.100 Biomarker disease BEFREE The other 28 patients with RCC which FDG accumulation was suppressed by TKI showed longer progression-free survival (3.6 months vs 6.5 months, P = 0.0026), but this suppression in most cases (96%) was temporary and FDG accumulation was accelerated when tumor demonstrated PD. 28068944 2017
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.100 Biomarker disease BEFREE Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Renal Cell Carcinoma. 28134692 2017
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1 		0.100 Biomarker disease BEFREE Max SUVmax assessed by FDG PET/CT prior to EVL and at 1 month after EVL treatment can accurately predict PFS and can guide decisions on whether to continue or change treatments for patients with EVL-treated RCC who suffer from adverse events. 28331985 2017